Gracell Biotechnologies Inc. Stock
Equities
GRCL
US38406L1035
Biotechnology & Medical Research
Latest transcript on Gracell Biotechnologies Inc.
Managers | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 17-04-30 |
Yi Li Xie
DFI | Director of Finance/CFO | 54 | 20-07-23 |
Wendy Li
CTO | Chief Tech/Sci/R&D Officer | 66 | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Cao
CEO | Chief Executive Officer | 66 | 17-04-30 |
Guo Tong Xu
BRD | Director/Board Member | 67 | 19-01-31 |
Guo Wei Wang
BRD | Director/Board Member | 63 | 20-02-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 112 M€ | +4.86% | - |
1st Jan change | Capi. | |
---|---|---|
+55.55% | 59.28B | |
+43.17% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |